These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Scientific overview of myasthenia gravis and an assessment of the role of plasmapheresis. Tindall RS Prog Clin Biol Res; 1982; 106():113-42. PubMed ID: 6757936 [No Abstract] [Full Text] [Related]
13. Current and future therapies for myasthenia gravis. Yi Q; Lefvert AK Drugs Aging; 1997 Aug; 11(2):132-9. PubMed ID: 9259176 [TBL] [Abstract][Full Text] [Related]
14. Myasthenic crisis: guidelines for prevention and treatment. Jani-Acsadi A; Lisak RP J Neurol Sci; 2007 Oct; 261(1-2):127-33. PubMed ID: 17544450 [TBL] [Abstract][Full Text] [Related]
15. Essentials in the management of myasthenia gravis. Galdi AP Am Fam Physician; 1978 Jun; 17(6):95-102. PubMed ID: 655080 [TBL] [Abstract][Full Text] [Related]
16. Treatment of acquired autoimmune myasthenia gravis: a topic review. Verma P; Oger J Can J Neurol Sci; 1992 Aug; 19(3):360-75. PubMed ID: 1393847 [TBL] [Abstract][Full Text] [Related]
18. [Contribution of intravenous immunoglobulins to the treatment of myasthenia]. Gajdos P Ann Med Interne (Paris); 2000 May; 151 Suppl 1():1S30-4. PubMed ID: 10896986 [TBL] [Abstract][Full Text] [Related]